APOA1 and ovarian carcinoma: In this study, we attempted to measure three serum biomarkers of ovarian cancer, CA125, transthyretin, and apolipoprotein A1, using a multiplex bead-based immunoassay system, and evaluated the combined effect of the three biomarkers for the diagnosis of ovarian cancer compared with those of the individual markers alone.